Comparative antibiotic failure rates in the treatment of community-acquired pneumonia: Results from a claims analysis

Introduction| Antibiotic treatment failure contributes to the economic and humanistic burdens of community-acquired pneumonia (CAP) by increasing morbidity, mortality, and healthcare costs. This study compared treatment failure rates of levofloxacin with those of other antibiotics in a large US sample.